Binding interactions with sevelamer and polystyrene sulfonate in vitro

Area of Science:

• Pharmacology
• Drug Interactions
• In Vitro Studies

Background:

• Sevelamer and polystyrene sulfonate are commonly used phosphate binders.
• Concomitant use with other medications may lead to drug-binding interactions.
• Understanding these interactions is crucial for optimizing patient therapy.

Purpose of the Study:

• To explore in vitro binding of 28 selected drugs to sevelamer and polystyrene sulfonate.
• To identify potentially new drug-binding interactions with these phosphate binders.
• To assess the influence of different pH levels on drug binding.

Main Methods:

• In vitro binding assays were performed using sevelamer (800 mg) and polystyrene sulfonate (15 g).
• Twenty-eight drugs were tested at pH levels of 1.5, 5.5, and 7.4.
• Drug concentrations were quantified after incubation and centrifugation to calculate mean relative binding (MRB).

Main Results:

• Fourteen potentially new binding interactions were identified with sevelamer.
• Twenty-three potentially new binding interactions were identified with polystyrene sulfonate.
• Relevant binding (MRB >20% at any pH) was observed for multiple drug-binder combinations.

Conclusions:

• Sevelamer and polystyrene sulfonate exhibit potentially new binding interactions with various drugs.
• These in vitro findings suggest a need for further in vivo investigation.
• Clinical relevance of these identified binding interactions requires further assessment in animal models or human studies.